---
title: "Alignment Healthcare, Inc. (ALHC.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ALHC.US.md"
symbol: "ALHC.US"
name: "Alignment Healthcare, Inc."
industry: "Managed Health Care"
datetime: "2026-06-13T17:57:01.192Z"
locales:
  - [en](https://longbridge.com/en/quote/ALHC.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALHC.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALHC.US.md)
---

# Alignment Healthcare, Inc. (ALHC.US)

## Company Overview

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc.

| Item | Detail |
|------|--------|
| Industry | Managed Health Care |
| Exchange | US Market |
| Website | [www.alignmenthealth.com](https://www.alignmenthealth.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-06-13T04:30:12.000Z

**Overall: B (0.29)**

**Industry**: Managed Health Care

| Metric | Value |
|--------|-------|
| Industry Ranking | 5 / 10 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 41.81% |  |
| Net Profit YoY | 121.85% |  |
| P/B Ratio | 19.74 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4082993004.25 |  |
| Revenue | 4256984000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 12.57% | B |
| Profit Margin | 0.47% | C |
| Gross Margin | 11.70% | D |
| Revenue YoY | 41.81% | A |
| Net Profit YoY | 121.85% | A |
| Total Assets YoY | 40.86% | A |
| Net Assets YoY | 89.81% | A |
| Cash Flow Margin | 1272.31% | A |
| OCF YoY | 41.81% | A |
| Turnover | 3.95 | A |
| Gearing Ratio | 83.60% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Alignment Healthcare, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "41.81%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "121.85%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "19.74",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4082993004.25",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "4256984000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "12.57%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "0.47%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "11.70%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "41.81%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "121.85%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "40.86%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "89.81%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "1272.31%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "41.81%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "3.95",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "83.60%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 206.15 | 7/10 | 200.41 | 172.85 | 160.43 |
| PB | 19.74 | 9/10 | 24.99 | 23.59 | 20.23 |
| PS (TTM) | 0.96 | 6/10 | 1.09 | 0.97 | 0.88 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Unitedhealth (UNH.US) | B | C | A | D | B | B |
| 02 | Elevance Health (ELV.US) | B | C | A | D | B | B |
| 03 | Humana (HUM.US) | C | B | A | D | B | B |
| 04 | HealthEquity (HQY.US) | B | C | C | B | B | B |
| 05 | Alignment Healthcare (ALHC.US) | C | A | A | E | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-06-10T04:00:00.000Z

Total Analysts: **14**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 10 | 71% |
| Overweight | 2 | 14% |
| Hold | 2 | 14% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 19.75 |
| Highest Target | 30.00 |
| Lowest Target | 16.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ALHC.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ALHC.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ALHC.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ALHC.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**